CUSIP: H9060V101
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
27,865,594
-
Share change
-
+4,526,363
-
Total reported value
-
$150,473,000
-
Price per share
-
$5.40
-
Number of holders
-
20
-
Value change
-
+$24,509,333
-
Number of buys
-
11
-
Number of sells
-
6
Quarterly Holders Quick Answers
What is CUSIP H9060V101?
CUSIP H9060V101 identifies VECT - VECTIVBIO HOLDING - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP H9060V101:
Institutional Holders of VECTIVBIO HOLDING - Stock (VECT) as of Q2 2022
As of 30 Jun 2022,
VECTIVBIO HOLDING - Stock (VECT) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,865,594 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, CHI Advisors LLC, Novo Holdings A/S, CITADEL ADVISORS LLC, Cormorant Asset Management, LP, Bpifrance SA, EVENTIDE ASSET MANAGEMENT, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Tekla Capital Management LLC, and MARSHALL WACE, LLP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.